Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluvoxamine for Adults With Mild to Moderate COVID-19: A Single-blind, Randomized, Placebo-controlled Trial

NCT04711863 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT04711863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04711863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluvoxamine for Adults With Mild to Moderate COVID-19: A Single-blind, Randomized, Placebo-controlled Trial
Lead sponsor
Asan Medical Center
Phase
Phase 2
Overall status
Suspended
Start date
January 16, 2021
Completion date
July 31, 2021
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, mild to moderate covid-19, severe acute respiratory syndrome coronavirus 2